Transcutaneous Laryngeal Ultrasound for Assessing Hyaluronic Acid Status in Patients Undergoing Injection Laryngoplasty
The Laryngoscope · 2024
DOI: 10.1002/lary.31614 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Chia-Fan Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Hyaluronic Acid, Laryngoplasty, Vocal Cord Paralysis, Ultrasonography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taipei Veterans General Hospital.
Abstract (Originalsprache)
Objective
Injection laryngoplasty (IL) with hyaluronic acid (HA) is an effective treatment for patients with glottic insufficiency. The duration of HA maintenance in the vocal fold remains unknown. In this study, transcutaneous laryngeal ultrasound (TLUS) was used to evaluate the absorption and migration of HA after IL. Subsequent management might be provided based on the TLUS finding.
Methods
Patients diagnosed with unilateral vocal fold paralysis (UVFP) or vocal fold atrophy were recruited. All patients underwent IL with HA in an office‐based setting along with TLUS to monitor the status of HA. The schedule of TLUS included assessments before and after IL until non‐visualization.
Results
The study population comprised 38 women and 17 men. Of the patients, 54.1% underwent IL for UVFP, whereas 45.9% underwent IL for vocal fold atrophy. Multivariate Cox regression analysis for factors affecting HA absorption revealed that the cause of injection was the most important independent predictor (hazard ratio [HR], 2.15; 95% confidence interval [CI], 1.03–4.46; p = 0.040). The duration of HA maintenance was significantly longer in patients with UVFP than in those with vocal fold atrophy (8.77 vs. 4.70 months, HR, 2.33; 95% CI, 5.47–8.18; p = 0.002).
Conclusion
TLUS is an objective assessment method for patients undergoing IL with HA. Subsequent tailor‐made management could be offered based on the TLUS findings during follow‐up. For patients at high risk of upper respiratory tract infection or who are intolerant to flexible nasopharyngoscopy, TLUS can be used as an alternative tool to evaluate the condition of the glottis after IL with HA. Level of Evidence 4 Laryngoscope , 134:4682–4687, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan.
- Department of Otorhinolaryngology, National Yang Ming Chiao Tung University Hospital, Yilan City, Taiwan.
ORCID-Profile: Chia-Fan Chang
Förderung
- Taipei Veterans General Hospital
Zitieren
APA
Chang, C. F., Kuo, Y. L., & Hsu, Y. B. (2024). Transcutaneous Laryngeal Ultrasound for Assessing Hyaluronic Acid Status in Patients Undergoing Injection Laryngoplasty. The Laryngoscope. https://doi.org/10.1002/lary.31614
Vancouver
Chang CF, Kuo YL, Hsu YB. Transcutaneous Laryngeal Ultrasound for Assessing Hyaluronic Acid Status in Patients Undergoing Injection Laryngoplasty. The Laryngoscope. 2024. doi:10.1002/lary.31614
BibTeX
@article{Chang2024,
author = {Chang, Chia-Fan and Kuo, Yen-Ling and Hsu, Yen-Bin},
title = {Transcutaneous Laryngeal Ultrasound for Assessing Hyaluronic Acid Status in Patients Undergoing Injection Laryngoplasty},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31614}
}
EUVIMED